The Scotts Miracle-Gro Company
The Scotts Miracle-Gro Company (SMG), unlike other cannabis companies (HMMJ) like Canopy Growth (CGC) (WEED) and Tilray (TLRY), has large exposure to the lawn and gardening business in the US. However, the company’s foray into the indoor gardening segment has been of interest to cannabis investors.
The overall consensus recommendation for SMG is a “hold,” which was unchanged from last month. Month-over-month, one analyst has maintained a “strong buy” on the stock. However, the number of analysts recommending a “buy” has dropped to two in the current month. The number of analysts recommending a “hold” remained unchanged at one, and three analysts continued to have a “sell” recommendation on the stock.
Analyst recommendations remained unchanged month-over-month, and the consensus price target on the company also remained unchanged at $90.3 in September. The company’s stock closed at $78.3 on September 11, which implies 15.3% upside from the current level.
SMG doesn’t cultivate cannabis, but it is exploring opportunities to do that. The company has partnered with the Flowr Corporation to build a research facility that will test the impact of nutrients and lighting on cannabis.